Synagistics Limited (Synagistics) filed its Monthly Return for Equity Issuer for the period ended 30 June 2026, showing no changes in either authorised or issued share capital and confirming full compliance with Hong Kong’s 25% minimum public-float rule.
Authorised and Issued Share Capital • Authorised share capital stood unchanged at 1.10 billion ordinary shares with a par value of HKD 0.0001 each, representing HKD 0.11 million in total nominal value. • Issued shares (excluding treasury) remained at 459.89 million. No new shares were issued, cancelled, or held in treasury during the month.
Equity Incentives and Potential Dilution • Share Option / Award Scheme: 556,600 share options were outstanding at month-end; none were exercised. The scheme still allows issuance of up to 26.22 million shares. • Successor Warrants: – Successor SPAC Warrants (stock code 02461): 120,750 warrants outstanding, each exercisable for 0.5 share on a cashless basis at HKD 11.50 before 30 October 2029. – Successor Promoter Warrants: 15.70 million warrants outstanding, same terms and expiry as above. • Other Issuable Shares: – Up to 52.10 million “Target Company Founder Earn-out Shares” may be issued between October 2025 and October 2029, subject to performance conditions. – 10.60 million Restricted Share Units (RSUs) remain unvested under the Share Award Scheme, following shareholder approval on 30 June 2026.
Liquidity & Compliance Synagistics affirmed that its public float comfortably meets the Initial Prescribed Threshold of 25% of issued shares, based on publicly available information.
Corporate Actions No conversions, warrant exercises, share option exercises, share repurchases, or other equity movements occurred in June 2026.
Governance Confirmation The filing, signed by Director Ms Tai Ho Yan Olive on 7 July 2026, confirms adherence to all applicable Hong Kong Listing Rules, corporate approvals, and legal requirements for any outstanding equity instruments.
The static capital base and adherence to listing regulations position Synagistics with a clear capital structure heading into the second half of 2026, while potential dilution remains contingent on future option exercises, warrant conversions, and earn-out conditions.
Comments